Oxford Cannabinoid Technologies Holdings is aiming to list on the OTC QB Market under the ticker OCTHF this November.
In relation to the admission, Harbor Access, a US strategic investor relations adviser, based in Stamford, Connecticut, has been appointed as North American investor relations advisor. Harbour will provide North American investor awareness support to the company for the listing.
Oxford Cannabinoid Technologies Holdings‘ COO, Clarissa Sowemimo-Coker, commented: “As we move towards finalising our US share trading facility on the OTC QB Market, local investor knowledge and support are key to optimising our designation.
“Harbor Access has worked with numerous dual-quoted companies, and we look forward to having their support.”
Managing partner of Harbor Access, Jonathan Paterson, added: “We are excited to work with the team at OCTP.
“The Company’s ongoing development of drug candidates for novel solutions for chronic pain management will offer an exciting new investment opportunity for the North American investment community.”
The company says the admission is an important strategic step and gives it greater exposure to a much wider audience of potential investors by easing cross-border trading for its US investors, in addition to its London Stock Exchange Main Market Listing.
There is no capital-raise being conducted in conjunction with the application to trading on the OCT QB.
[activecampaign form=31]
